Key facts
- This page summarizes Brian Robb Douglass's Form 4 filing for REPLIGEN CORP (RGEN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 08 Oct 2026, 16:40.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Mr. Douglass was awarded 700 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
Footnote F2
225 shares will vest on each of October 6, 2027, October 6, 2028, and October 6, 2029.